April 19 2012
Anxiety is an issue that everyone deals with, whether it be the anxiety of the first day of school, meeting a new client, or a first date, it’s a pertinent issue in everyone’s life. The topic my research paper was given was one on anti-anxiety medications and their effects, I chose an article written by Moira Rynn, M.D., Anthony Puliafico, Ph.D., Charlotte Heleniak, B.A., Pranav Rikhi, Kareem Ghalib, M.D., and Hilary Vidair, Ph.D. that examines the effects of these drugs, mainly in random control trials.
I found my source by heading to the EBSCO page, and following steps 1-through-9. I entered in the keyword “Anxiety Medications” and briefly read through the titles, and then the abstracts, until I found one that seemed pertinent, yet was of adequate length to fully analyze and to write this summary on. The content of the journal was focused on the medications used to treat various anxiety disorders, why they work the way they do (what part of the brain they target), and the methods the medications are used under(e.g. RCT). Anxiety disorders are, according to the journal, the most common type of psychiatric disorder diagnosed in children. Having a prevalence rate of 6 to 20%, and an average age of onset ranging from 6 to 21 years, anxiety disorders can wreak havoc on both the personal and social lives of children, adolescents, and adults; often leading to difficulties such as depression, substance abuse and dependence, and suicidal behavior.
The journal briefly touched on multiple types of anxiety, the first being Generalized Anxiety Disorder. They gave an example story, more or less talking about a young girl having anxiety that would build at the pace of a snowball rolling down a hill. They put 22 children and young adults (ages 5-17) on a drug called Sertraline. Sertraline was found to be superior to a placebo for reducing anxiety symptoms, but they did not...
Cited: Rynn, M., Puliafico, A., Heleniak, C., Rikhi, P., Ghalib, K., & Vidair, H. (2011). Advances in pharmacotherapy for pediatric anxiety disorders. Depression & Anxiety (1091-4269), 28(1), 76-87. doi:10.1002/da.20769
Please join StudyMode to read the full document